George W. Lloyd, EVP, Investments & CLO at Royalty Pharma plc (RPRX), sold 125,558 shares at $37.03 ($4.7M) on 2023-03-29, disclosed to the SEC on 2023-03-30.
Open-market sale of $4.7M RPRX by EVP, Investments & CLO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.06 | 100,000 | $3.7M | 79.7% |
| 2 | $37.03 | 12,779 | $473K | 10.2% |
| 3 | $37.03 | 12,779 | $473K | 10.2% |
| Total | $37.05 avg | 125,558 | $4.7M | 100% |
| Filing → |
| RPRX | SELL | 2025-11-21 | $10.4M | — | Filing → |
| RPRX | SELL | 2023-06-06 | $13.0M | — | Filing → |
| RPRX | SELL | 2023-02-27 | $1.9M | — | Filing → |